While many cases are treatable, a subset can become highly aggressive, spreading to distant organs and resisting conventional therapies
Together, the companies aim to deliver an integrated toolkit for biomarker discovery and clinical research
The Phase III METEOROID study met its primary endpoint, with ENSPRYNG cutting the risk of a first relapse by 68% compared to placebo in adults and adolescents
IgAN is a rare, progressive kidney disease driven by abnormal IgA immune complexes that deposit in the kidneys
By prioritising absolute compliance, leveraging the power of digital tools, and aligning with government policies, the sector is locking in its future leadership
Narasimhan’s appointment underscores the growing importance of AI in transforming drug discovery
The innovation is particularly suited for bone and cartilage repair
The company said it is supporting the ongoing investigation and reiterated its commitment to patient safety.
The drug is designed to provide temporary relief from cough caused by throat and bronchial irritation
Subscribe To Our Newsletter & Stay Updated
